Abstract
Introduction
In sub-Saharan Africa, home to around 23 million people living with HIV, 1 accurate measurement of HIV prevalence is essential for policy planning and resource allocation. Demographic and Health Surveys (DHS) and other national population-based surveys have served as important data sources for such measurement in the past three decades. 2, 3 These surveys are useful because they contain detailed demographic and risk characteristics and possibly outcome variables of interest (e.g., HIV status) at the individual and household level. However, significant refusal rates in these surveys are often reported 4 and failure to address the refusal issue may severely undermine the reliability of estimates, because those who refuse may be systematically different from the survey participants. 5, 6 In this paper, we propose two methods to estimate lower and upper bounds of HIV prevalence in the presence of refusals (the "refusers") in a DHS survey under two mild and intuitive assumptions: (A1)
For those who have never taken an HIV test before, the refusers are at least as likely to be HIV positive as the test participants; (A2) Among the refusers, those who have taken an HIV test before are at least as likely to be HIV positive as those without a previous testing experience.
The first method requires the existence of a set of supplementary longitudinal data, which permits estimation of the relative risk of HIV between participants who have never taken an HIV test before and the refusers who have taken a test before. In the second method, the researcher specifies this relative risk to study the sensitivity of the bounds to the relative risk. Thus, this method offers a practical alternative to evaluatethe significance of the refusal issue when a suitable longitudinal data set is unavailable.
Data sources
The primary data source for this study is the 2004 Malawi Demographic Health Survey (MDHS), which is a nationally-representative survey. In addition, we use a longitudinal data set collected under the Malawi Diffusion and Ideational Change Project (MDICP). To focus on refusals, we exclude all missing observations due to non-contact.
a
MDHS
The 2004 MDHS is a two stage survey using households from 28 districts in Malawi. All women aged 15-49 in a selected household were eligible for interview. In about one in three selected households, male members of the household aged 15-54 were also surveyed and an HIV test was offered to both male and female members. 8 However, HIV test was successfully carried out only for 67 percent of the eligible a A major reason for non-contact is migration, which is potentially an important issue as migrants appear to have higher HIV prevalence than non-migrants in Malawi. 7 While migration is beyond the scope of this study, the bound estimators presented below can be extended to include migrants by re-interpreting refusal as migration. 3 individuals with refusal accounting for the majority of missing HIV status for the non-participants. 8 The proportion of refusals was higher in the Central region (26 percent) than in the Southern or the Northern regions (21 percent and 14 percent, respectively). The refusal rate was slightly higher in urban (25 percent) than in rural areas (22 percent).
We confine the 2004 MDHS sample to those aged under 49 to make the male and female populations comparable. Following a Malawi National Statistical Office report, we omit Lilongwe district, which has an unusually high refusal rate and low observed prevalence. 8 We also exclude those who refused to answer the individual questionnaire, those whose HIV testing results are not available for reasons other than refusal (e.g., non-contact and technical problem), and those whose previous HIV testing status is unknown. As a result, we have a total of 6,343 eligible individuals (3,511 women and 2,832 men) in our sample.
MDICP
The MDICP is an ongoing longitudinal study, which includes married women and their husbands randomly drawn from 120 villages in a total of three rural districts with one district from each of the Southern, Central, and Northern regions. While the initial sample is not designed to be representative of rural Malawi, its sample characteristics closely matched those of the rural sample in the 1996 MDHS. 9 We restrict our sample to those aged 15-49 who appear in both the third and fourth phases 
in general is not the same as ρ because some respondents, particularly those who already know they are (likely to be) HIV positive, may refuse to take an HIV test out of fear that their HIV status be known to others.
Since we generally know little about the reasons for refusals, we only wish to make weak and plausible assumptions. To motivate assumptions (A1) and (A2), we note the following two points: First, individuals may know the risk of HIV infection even without HIV tests because they know their behavior.
Hence, those who are at a higher risk of HIV may be more likely to refuse HIV tests. Second, previous testing experience may be informative of current HIV status because, for example, those who have engaged in risky sexual behaviour may be more likely to take HIV tests out of necessity. Based on these considerations, we propose to estimate lower and upper bounds of  under the following assumptions: To derive the bound estimators, we first decompose  as follows:
By applying eq. (1) to eq. (2), we obtain the following lower bound   and upper bound   satisfying
These bounds cannot be directly calculated from DHS, because
is unknown in general. However, with a suitable longitudinal data set, it may be possible to estimate this quantity under some additional assumptions. Below, we first develop a method when such a longitudinal data set is available. We then consider a practical solution in the absence of a longitudinal data set.
Method 1: When auxiliary longitudinal data is available
In our empirical example, we know the HIV status of the refusers in MDICP-4 from the MDICP-3 test results. However, since MDICP is not nationally representative, it would be inappropriate to estimate 
The numerator and denominator of the last line of eq. (5) can be estimated by the proportions of HIV positive among those who have previously taken an HIV test in MDHS and MDICP data, respectively. Using eq. (5), the following holds: (6) and (8) below. For the rest, we chose not to apply the weights in our main results as we do not have corresponding weights in the MDICP data. In the Appendix, we consider alternative weighting schemes and show that our main results remain unaffected by the choice of weights.
Note here that eq. (1) is an assumption that has to be empirically validated. When the assumption is violated, the lower bound is not guaranteed to be smaller than the upper bound.
Method 2: When auxiliary longitudinal data is unavailable
We now turn to the case where a longitudinal data set is not available. In this case, we are generally unable to calculate the bounds based on eqs. (6) and (8) . However, it is still possible to evaluate the influence of refusals. To see this point, define the relative risk
of HIV between non-refusers with no previous testing experience and refusers with previous testing experience:
which is the ratio of the right-hand-side to the left-hand-side in eq. (1). Given k , we can use the following expressions of   and   , which can be estimated from MDHS:
These expressions show that the width of the bounds, (2), (9), and (10):
Notice that these bounds are different from the complete-case estimator even when 1 = k , because the complete-case estimator is consistent for
which is the same as eq. (11) if and only if
. This difference can also be seen from the fact that the complete-case estimator does not make use of information from the previous testing experience.
Results
In theory, the foregoing derivations allow us to apply the methods to any sub-population of interest.
However, when using eqs. (3) and (4) with Method 1, we must ensure that the bounds are empirically 7 consistent with eq. (1). This issue is especially important when the relevant sub-sample is small and a few positive HIV cases can significantly influence the results. To avoid this problem, we let k to depend only on the sex of individuals while other quantities in eqs. (6) and (8) these three regions, urban prevalence is substantially higher than rural prevalence. In fact, the rural upper bound is lower than the urban lower bound for both males and females in all regions with the exception of female prevalence in the Central region. Third, the tightness of the bounds varies across regions. The bounds in the Northern region are tighter than those in the Central and Southern regions. These three points indicate that the policies to tackle HIV would need to take into account the geographic differences in HIV prevalence.
Fourth, there is also a wide gap between male and female HIV prevalences. Male upper bound is lower than female lower bound in all locations we considered. Further, the bounds for males are generally much tighter than those for females. This is in part because men generally have lower HIV prevalence. In particular, the HIV prevalence for the participants with no previous HIV testing (i.e., In Table 2 , we report the lower and upper bounds for {1,2,3,4}  k calculated solely from the MDHS data set. While the choice of these values is subjective, it could serve as rule-of-thumb figures to use in Africa given the empirical estimtates of k used in Method 1. Table 2 shows that both the lower and upper bounds tend to increase as k goes up. However, when no one with a previous testing experience refuses to participate in the sample, the lower bound does not vary with k . This is indeed the case for males in the rural Northern region and females in the urban 9 Central region.
The table also shows that the tightness of the bounds varies substantially between the sexes, between urban and rural areas, and across regions. The bounds are reasonably tight when k is less than 2. However, when 4 = k , the width of the bounds can be as large as 16.2 percentage points (females in the urban Southern region) and as small as 0.9 percentage points (males in the urban Northern region).
Overall, the results from Methods 1 and 2 indicate that we need to exercise greater caution when interpreting female HIV prevalence.
Discussion
Existing studies on refusal bias in the estimation of HIV prevalence typically either provide some evidence of the existence of the bias or try to correct for the bias by making some (often strong) behavioral assumptions about the subjects. In this paper, we have instead derived plausible lower and upper bounds for HIV prevalence under mild and intuitive assumptions by exploiting a longitudinal data set in addition to the DHS data set. This study complements the results of an earlier report on the potential bias due to refusal/absence using the MDICP data 10 by showing the significance of the refusal issue in the estimation of the national HIV prevalence based on the MDHS data set.
We find that the prevalence bounds are fairly tight for males and also close to the complete case estimator. Since these bounds are created under very mild conditions, the refusal bias in the complete-case MDHS estimates for males is likely to be small. On the other hand, the bounds for females are much wider. Based on Method 1, the upper bound for women (0.1817) being over three percentage points above the complete-case estimate (0.1521) (Further details available in the Appendix). This may be because women are more likely to suffer from and thus sensitive to the stigma associated with HIV/AIDS.
This in turn suggests that the refusers, especially those with a previous testing experience, may be systematically different from the non-refusers. The results based on Method 2 shows that the significance of refusal can be meaningfully evaluated by varying the value k within a plausible range.
Our results also provide encouraging evidence that longitudinal data sets can be fruitfully used to supplement DHS data for drawing inferences, even when the longitudinal study is not nationally
representative. This point is important because longitudinal surveys in such settings are often based on more stable populations in rural communities and not necessarily nationally representative (for example, longitudinal studies of malaria in Africa have been typically conducted in rural communities). However, they differ from urban counterparts both in access to treatment and in demographic and socioeconomic characteristics and inferences drawn from these studies cannot be directly extrapolated to the general population. We addressed this issue by explicitly taking into account the differences between the MDICP 10 and non-MDICP populations.
Given the increasing number of longitudinal health studies, 11, 12, 13, 14 it is likely that we will be able to obtain better empirical estimates of k over time, which in turn would allow us to derive more reliable bounds in areas where relevant longitudinal survey is unavailable.
12 Appendix: Additional tables Tables 3 and 4 are the same as Tables 1 and 2 except that we apply the MDHS sample weights in the calculation of joint probabilities in eqs. (3) and (4) In Table 5 Table 5 with Table 1 shows, the use of census-based estimates of ) , | (
does not alter the results much overall.
Finally, we report the complete-case estimates of the HIV prevalence in Table 6 . 
